All In Biotech

Drug Trial Radar · NCT01290341

Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

A Phase 3 Double-Blind, Randomized, Placebo-Controlled,Multicenter, Parallel Group Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

Last checked: Nov 20, 2026Latest source record: Sep 26, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 860 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

860

Actual

Start

Feb 2011

Primary completion

Nov 2011

Study completion Dec 2011

Sponsor

Lead sponsor
Merz North America, Inc.Industry
Sponsor type
Industry
First posted
Feb 7, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a 6-week, double-blind, randomized, placebo-controlled, multicenter, parallel group Phase 3 study of NAFT-600 applied once a day for 2 weeks compared to vehicle (placebo) in the treatment of tinea pedis.

Conditions

  • Tinea Pedis

Interventions

  • NAFT-600 (naftin 2 % gel)Drug

    Topical; applied once daily for two weeks

  • PlaceboDrug

    Topical; applied once daily for two weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete Cure of Interdigital Tinea PedisTime frame: Visit 4/ Week 6

Locations

23 sites in 1 country. Site status is shown where the registry gives one.

  • Radiant Research, Inc.

    Tucson, Arizona

  • T. Joseph Raoof, MD, Inc.

    Encino, California

  • Walter K. Nahm, MD, PhD, Inc.

    San Diego, California

  • Colorado Medical Research Center

    Denver, Colorado

  • Longmont Clinic, PC

    Longmont, Colorado

  • Tampa Bay Medical Research

    Clearwater, Florida

  • Lake Washington Foot and Ankle Center

    Melbourne, Florida

  • Clinical Research Atlanta

    Stockbridge, Georgia

  • Hudson Dermatology

    Evansville, Indiana

  • Department of Veterans Affairs

    Minneapolis, Minnesota

  • Academic Dermatology Associates

    Albuquerque, New Mexico

  • Radiant Research, Inc

    Cincinnati, Ohio

  • Radiant Research, Inc.

    Columbus, Ohio

  • Oregon Dermatology & Research Center

    Portland, Oregon

  • Temple University- School of Podiatric Medicine

    Philadelphia, Pennsylvania

  • Palmetto Clinical Trial Services, LLC

    Simpsonville, South Carolina

  • DermResearch, Inc.

    Austin, Texas

  • J&S Studies, Inc.

    College Station, Texas

  • Research Across America

    Dallas, Texas

  • Endeavor Clinical Trials, PA

    San Antonio, Texas

  • Progressive Clinical Research

    San Antonio, Texas

  • The Education and Research Foundation, Inc.

    Lynchburg, Virginia

  • Madison Skin and Research, Inc

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.